Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study

Summary: Background: Fewer than 25% of patients with atherosclerotic cardiovascular disease in countries of low and middle income (LMICs) use guideline-directed drugs for secondary prevention. A fixed-dose combination polypill might improve cardiovascular outcomes by increasing prescription rates a...

Full description

Bibliographic Details
Main Authors: John K Lin, MD, Andrew E Moran, MD, Kirsten Bibbins-Domingo, MD, Bode Falase, FRCS, Andrea Pedroza Tobias, MSC, Charuta N Mandke, DOMS, Dhruv S Kazi, MD
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X19303390